Daniel Grunder
Vorsitzender bei GoodWind Holding GmbH
Aktive Positionen von Daniel Grunder
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Welle Holding AG + Co. KG
Welle Holding AG + Co. KG Home FurnishingsConsumer Durables Welle Holding AG + Co. KG manufactures wooden and upholstered furniture. It provides furniture for kitchen, babies, children and teenagers. The company is headquartered in Paderborn, Germany. | Direktor/Vorstandsmitglied | - | - |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Direktor/Vorstandsmitglied | - | - |
GoodWind Holding GmbH
GoodWind Holding GmbH Financial ConglomeratesFinance GoodWind Holding GmbH is a Swiss company that specializes in the acquisition, management, and sale of securities and similar assets. The private company is based in Baar, Switzerland. The company also handle financing and fiduciary transactions. | Vorsitzender | - | - |
Karriereverlauf von Daniel Grunder
Statistik
International
Schweiz | 3 |
Deutschland | 2 |
Operativ
Director/Board Member | 2 |
Chairman | 1 |
Sektoral
Consumer Durables | 2 |
Health Technology | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Welle Holding AG + Co. KG
Welle Holding AG + Co. KG Home FurnishingsConsumer Durables Welle Holding AG + Co. KG manufactures wooden and upholstered furniture. It provides furniture for kitchen, babies, children and teenagers. The company is headquartered in Paderborn, Germany. | Consumer Durables |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Health Technology |
GoodWind Holding GmbH
GoodWind Holding GmbH Financial ConglomeratesFinance GoodWind Holding GmbH is a Swiss company that specializes in the acquisition, management, and sale of securities and similar assets. The private company is based in Baar, Switzerland. The company also handle financing and fiduciary transactions. | Finance |
- Börse
- Insiders
- Daniel Grunder
- Erfahrung